Health Trials

Observational Epidemiological Study of Patients Suffering From Systemic Amyloidosis

ConditionCardiomyopathy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

observational epidemiological study of patients affected by systemic amyloidosis

Eligibility criteria

Qualifiers

patients diagnosed with amyloidosis or asymptomatic carriers of mutations in the transthyretin gene

minimum age of 18 years at the time of diagnosis

obtaining informed consent

Disqualifiers

nothing

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov